Innovating.works Conecta tu I+D

NeuroNanotech: Nanoplatforms for Neuroscience BOSTON SCIENTIFIC LIMITED participó en un HORIZON EUROPE: HORIZON-MSCA-2023-DN-01 NeuroNanotech will train eleven researchers to tackle one of the major challenges in Europe’s ageing population - neurological diseases. The...
2024-07-02 - 2028-12-31 | Financiado

Newlife: New remote non-invasive monitoring solutions for ensuring the health of mothers and babies before an... BOSTON SCIENTIFIC LIMITED participó en un HORIZON EUROPE: HORIZON-KDT-JU-2021-1-IA There is increasing focus on the well being of mothers and babies, both before and after delivery and early detection of pathologies to prev...
2022-12-01 - 2025-12-31 | Financiado

MedTrainPlus: MedTrain+: Postdoctoral Career Development and Mobility Fellowships in Medical Device Research Evolv... BOSTON SCIENTIFIC LIMITED participó en un HORIZON EUROPE: HORIZON-MSCA-2021-COFUND-01 MedTrain+ is an advanced Industry-Academia Training, Career Development, and Mobility Fellowship Programme in Medical Device R&D at CÚRAM. T...
2022-10-12 - 2027-11-30 | Financiado

2D-EPL: Graphene Flagship 2D Experimental Pilot Line BOSTON SCIENTIFIC LIMITED participó en un H2020: The 2D Experimental Pilot Line (2D-EPL) project will establish a European ecosystem for prototype production of Graphene and Related Materia...
2020-10-28 - 2024-09-30 | Financiado

Moore4Medical: Accelerating Innovation in Microfabricated Medical Devices BOSTON SCIENTIFIC LIMITED participó en un H2020: H2020-ECSEL-2019-1-IA-two-stage Compared to the pace of innovation in electronic consumer products, the pace of innovation for medical devices is lagging behind. It is the...
2020-05-19 - 2023-09-30 | Financiado

GrapheneCore3: Graphene Flagship Core Project 3 BOSTON SCIENTIFIC LIMITED participó en un H2020: This proposal describes the third core project of the Graphene Flagship. It forms the fourth phase of the FET flagship and is characterized...
2020-02-12 - 2023-09-30 | Financiado

BRAV3: Computational biomechanics and bioengineering 3D printing to develop a personalized regenerative bio... BOSTON SCIENTIFIC LIMITED participó en un H2020: H2020-SC1-BHC-2018-2020 Ischemic heart disease is the main cause of death in the EU, straining patients and economies. Regenerative Medicine has failed at deliverin...
2019-12-06 - 2024-12-31 | Financiado

UWIPOM2: ULTRA EFFICIENT WIRELESS POWERED MICRO ROBOTIC JOINT FOR HEALTH APPLICATIONS BOSTON SCIENTIFIC LIMITED participó en un H2020: H2020-FETOPEN-2018-2020 This project seeks to develop the first micrometric-size Ultra-Efficient Wireless POwered Micro-robotic joint (UWIPOM2), enabling the creati...
2019-08-30 - 2023-06-30 | Financiado

FIT4FoF: Making our Workforce Fit for the Factory of the Future BOSTON SCIENTIFIC LIMITED participó en un H2020: H2020-NMBP-TR-IND-2018-2020 Increased introduction of digital technologies into manufacturing is leading to increased automation. Estimates indicate that the potential...
2018-09-17 - 2021-12-31 | Financiado

DELIVER: DELIVERy of advanced therapies for diabetes training network BOSTON SCIENTIFIC LIMITED participó en un H2020: H2020-MSCA-ITN-2018 The DELIVER EID programme aims to equip 6 industrial PhD graduates with all of the tools required to become creative, entrepreneurial and in...
2018-08-20 - 2022-12-31 | Financiado

BioImplant ITN: European Training Network to develop Improved Bioresorbable Materials for Orthopaedic and Vascular I... BOSTON SCIENTIFIC LIMITED participó en un H2020: H2020-MSCA-ITN-2018 BioImplant ITN is a European Industrial Doctorate (EID) programme that will provide world-class multidisciplinary training to a new generati...
2018-08-17 - 2023-06-30 | Financiado

GrapheneCore2: Graphene Flagship Core Project 2 BOSTON SCIENTIFIC LIMITED participó en un H2020: This proposal describes the third stage of the EC-funded part of the Graphene Flagship. It builds upon the results achieved in the ramp-up p...
2018-04-03 - 2020-03-31 | Financiado

InSilc: InSilc In silico trials for drug eluting BVS design development and evaluation BOSTON SCIENTIFIC LIMITED participó en un H2020: H2020-SC1-2016-2017 The aim of InSilc is to develop an in-silico clinical trial (ISCT) platform for designing, developing and assessing drug-eluting bioresorbab...
2017-10-16 - 2021-04-30 | Financiado

OPTOGENERAPY: Optogenetic Protein Therapy for Multiple Sclerosis BOSTON SCIENTIFIC LIMITED participó en un H2020: H2020-NMBP-2016-2017 Optogenerapy proposes a new interferon-ß (IFN-ß) drug delivery system to revolutionize Multiple Sclerosis treatment. The aim is to develop...
2016-11-23 - 2020-01-31 | Financiado

COMPOSITION: Ecosystem for Collaborative Manufacturing Processes Intra and Interfactory Integration and Automa... BOSTON SCIENTIFIC LIMITED participó en un H2020: H2020-IND-CE-2016-17 Data and services have become the key factor in manufacturing processes. The need to react on dynamically changing market demands is dramati...
2016-08-25 - 2019-08-31 | Financiado

DRIVE: Diabetes Reversing Implants with enhanced Viability and long term Efficacy BOSTON SCIENTIFIC LIMITED participó en un H2020: H2020-NMP-2014-2015 Diabetes mellitus is a chronic disease characterised by high blood glucose due to inadequate insulin production and/or insulin resistance wh...
2015-05-13 - 2019-05-31 | Financiado

AMCARE: Advanced Materials for Cardiac Regeneration AMCARE BOSTON SCIENTIFIC LIMITED participó en un FP7: The Advanced Materials for Cardiac Regeneration (AMCARE) consortium aims to establish a translational research program to develop truly rest...
Financiado

BSL